MedPage Today on MSN
Estradiol patch matches LHRH agonists for locally advanced prostate cancer
Similar 3-year metastasis-free survival, fewer hot flashes, more gynecomastia ...
Among US men with grade group 1 (GG1) prostate cancer, about 1 in 6 had intermediate- or high-risk disease, along with increased rates of adverse pathology and cancer-specific mortality. This finding ...
Stage 1 prostate adenocarcinoma is localized, non-aggressive, and often detected through routine screenings like PSA tests and DREs. Diagnosis involves PSA levels, Gleason scores, and possibly ...
The prognosis of grade group 1 prostate cancer varies widely, with high-risk features increasing the possibility of adverse pathology, biochemical recurrence, and in some cases, death. Gleason grade ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results